Healthcare Services

Candidiasis therapeutics market outlook with growth drivers

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Candidiasis Therapeutics Market Over The 2026–2030 Period?

The candidiasis therapeutics market size has experienced consistent growth in recent years. It is anticipated to increase from $3.29 billion in 2025 to $3.4 billion in 2026, driven by a compound annual growth rate (CAGR) of 3.5%. This historic expansion is largely due to factors such as the increasing prevalence of immunocompromised patient populations, a rising incidence of hospital-acquired fungal infections, the widespread use of broad-spectrum antibiotics, the availability of established antifungal drug classes, and the growth of hospital-based infectious disease care.

The candidiasis therapeutics market is anticipated to show consistent expansion in the coming years. Its value is expected to reach $4.03 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.3%. This projected growth can be attributed to increased research into novel antifungal drug classifications, growing awareness of managing antifungal resistance, wider embrace of outpatient antifungal treatments, an expanding focus on pediatric candidiasis therapies, and rising investments in the development of infectious disease drugs. Significant trends during this forecast period encompass the escalating development of targeted antifungal therapies, a stronger emphasis on early and accurate diagnosis, the increased utilization of combination antifungal treatments, the expansion of available oral and systemic treatment options, and enhanced monitoring of drug resistance patterns.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/candidiasis-therapeutics-global-market-report

What Primary Drivers Are Shaping The Candidiasis Therapeutics Market?

The growing number of clinical trials is anticipated to drive the expansion of the candidiasis therapeutics market in the coming years. Clinical trials are research investigations designed to assess the safety and efficacy of new medical therapies, interventions, pharmaceuticals, or devices in humans. These trials play a vital role in advancing candidiasis therapeutics by establishing a methodical and stringent process to evaluate the safety and effectiveness of prospective treatments. For example, in May 2023, data from ClinicalTrials.gov, a component of the National Institutes of Health (NIH), a US-based government agency dedicated to medical research, showed that approximately 437,533 clinical trials were registered in 2023, compared to 399,499 registered studies in 2022, across all 50 states of the United States and 221 countries. Therefore, the increasing volume of clinical trials is boosting the growth of the candidiasis therapeutics market.

How Is The Candidiasis Therapeutics Market Categorized Across Its Segment Groups?

The candidiasis therapeutics market covered in this report is segmented –

1) By Treatment Type: Medication, Supportive Therapy

2) By Anatomy Type: Oral Candidiasis, Vulvovaginal Candidiasis, Cutaneous Candidiasis, Invasive Candidiasis, Systemic Candidiasis

3) By Mode Of Administration: Injectable, Oral, Other Mode Of Administrations

4) By Patient Population: Adults, Pediatrics

5) By End User: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Medication: Antifungal Drugs, Topical Treatments, Systemic Treatments

2) By Supportive Therapy: Probiotics, Symptom Management Therapies, Adjunct Nutritional Support

What Trends Are Affecting The Growth Of The Candidiasis Therapeutics Market?

Companies in the Candidiasis Therapeutics market are prioritizing the development of cutting-edge solutions, such as echinocandin antifungal therapy, to boost treatment effectiveness, lessen resistance, and improve patient results in managing invasive and systemic Candida infections. Echinocandin antifungal therapy is a category of drugs that stops β-(1,3)-D-glucan synthesis in fungal cell walls, providing effective treatment for severe invasive Candida infections. As an illustration, in March 2023, Cidara Therapeutics Inc., a US-based biotech company, collaborated with Melinta Therapeutics, a US-based biopharmaceutical company, and secured U.S. FDA approval for REZZAYO (rezafungin for injection) for adults with candidemia and invasive candidiasis who have limited or no alternative treatment options. REZZAYO is a groundbreaking once-weekly echinocandin antifungal, marking the first new treatment choice for these infections in over a decade.

Which Firms Are Influencing Competition In The Candidiasis Therapeutics Market?

Major companies operating in the candidiasis therapeutics market are Pfizer Inc., Biocon Limited, Torrent Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca plc, GSK plc, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Cipla Inc., Lupin Limited, Basilea Pharmaceutica Ltd., WOCKHARDT Limited, Cidara Therapeutics Inc., Amplyx Pharmaceuticals Inc., SCYNEXIS Inc., Mycovia Pharmaceuticals Inc., NovaBiotics Inc., Matinas BioPharma Holdings Inc.

Get The Full Candidiasis Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/candidiasis-therapeutics-global-market-report

Which Region Has The Greatest Market Share In The Candidiasis Therapeutics Market?

North America was the largest region in the candidiasis therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candidiasis therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Candidiasis Therapeutics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/candidiasis-therapeutics-global-market-report

Browse Through More Reports Similar to the Global Candidiasis Therapeutics Market 2026, By The Business Research Company

Antifungals Market Report 2026

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Yeast Infection Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Systemic Aspergillosis And Systemic Candidiasis Market Report 2026

https://www.thebusinessresearchcompany.com/report/systemic-aspergillosis-and-systemic-candidiasis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795